期刊文献+

半边旗5F对硬皮病成纤维细胞Caspase-3活性的影响 被引量:1

Effects of Pteris Semipinnata 5F on Caspase-3 of Systemic Scleroderma Skin Fibroblasts
原文传递
导出
摘要 目的:探讨半边旗5F对凋亡有关的酶Caspase-3的影响,进而了解该酶诱导系统性硬皮病患者皮肤成纤维细胞凋亡的机制。方法:用光度检测法、RT-PCR法测定半边旗5F对Caspase-3的酶活性、mRNA表达量的变化。结果:在半边旗5F作用下,Caspase-3的酶活性增高,mRNA表达增多。这些变化在一定范围内随着药物浓度的增高和作用时间的延长而增强。结论:半边旗5F通过影响Caspase-3的mRNA的表达量而增高酶的活性,是诱导系统性硬皮病患者皮肤成纤维细胞的凋亡的机制之一。 Objectives:To study the effects of peris semipinnata 5F on Caspase-3 enzyme apoptosis correlated of systemic scleroderma(SSc) skin fibroblasts and find the cause of apoptotic induction of pteris Semipinnata 5F on SSc Skin Fibroblasts.Methods:We detected the change of enzyme activity,mRNA expression of Caspase-3 by photometric determination and RT-PCR.Results:The result showed that 5F increased the level of Caspase-3 enzyme activity and the expression of mRNA along with the increasing the concentration of th...
出处 《中国误诊学杂志》 CAS 2009年第5期1015-1017,共3页 Chinese Journal of Misdiagnostics
关键词 硬皮病 局部性/酶学 半胱氨酸天冬氨酸蛋白酶/遗传学/药物作用 二萜类/药理学 抗肿瘤药(中药)/药理学 Scleroderma Localized/enzymology Caspases/genetics/drug effects Diterpenes/pharmacology ANTINEOPLASTIC DRUG(TCD)/pharmacology
  • 相关文献

参考文献3

二级参考文献7

共引文献3

同被引文献14

  • 1Seibold JR.Scleroderma[ M]//Ruddy S,Harris ED,Sledge CB.6th ed.Kelley' s Textbook of Rheumatology.6th ed.Philadelphia:Saun-ders,2001:1211-1239.
  • 2Fett N,Werth VP.Update on morphea:part Ⅱ.Outcome measures and treatment [J].J Am Acad Dermatol,2011,64(2):231-244.
  • 3Kroft EB,Groeneveld TJ,Seyger MM,et al.Efficacy of topical tacroli-mus 0.1% inactivepiaquemorphea:randomized,double-blined,emolli-ent-controlled pilot study[J].Am J Clin Dermatol,2009,10(3):181-187.
  • 4Derk CT,Huaman G,Jimenez SA.A retrospective randomly selected co-hort study of D-penicillamine treatment in rapidly prognessive diffuse cutaneous systemic sclerosis of recent onset [ J ].Br J Dermatol,2008,158(5):1063-1068.
  • 5Kuhn A,Haust M,Ruland V,et al.Effect of bosentan on skin fibrosis in patients with systemic sclerosis:a prospective,open-label noncompara-tive trial [ J ].Rheumatology(Oxford),2010,49(7):1336-1345.
  • 6Tzouvelekis A,Galanopoulos N,Bouros E,et al.Effect and safety of my-cophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease:a meta-analysis [ J ].Pulm Med,2012,2012:143637.
  • 7孙钰.治疗风湿免疫性疾病的药物研究进展[J].中南药学,2009,7(9):693-699. 被引量:9
  • 8黄继宗,瞿祖德,严建华,郭国侠,任金木.胸导管引流治疗系统性硬化症的临床研究[J].铁道医学,1998,26(6):380-381. 被引量:3
  • 9黄继宗,朱绍,徐锦盛,张云诚,任含木,沈喜梅.胸导管淋巴液引流治疗难治性哮喘机理初探[J].铁道医学,1990,18(6):351-352. 被引量:2
  • 10系统性硬化病诊断及治疗指南[J].中华风湿病学杂志,2011,15(4):256-259. 被引量:61

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部